不适合移植的大 B 细胞淋巴瘤二线使用 axicabtagene ciloleucel:ALYCANTE 最终分析
Second-line axicabtagene ciloleucel in large B-cell lymphoma ineligible for transplantation: ALYCANTE final analysis.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Cutaneous T-cell lymphomas other than mycosis fungoides: Unusual clinical and pathologic presentations: a report of the 2023 SH-EA4HP Lymphoma Workshop (session 4).
Cutaneous T-cell lymphomas other than mycosis fungoides: Unusual clinical and pathologic presentations: a report of the 2023 SH-EA4HP Lymphoma Workshop (session 4).
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
2023年11月9日至11日,在德克萨斯州休斯顿举行的2023年血液病理学会-欧洲血液病理学协会研讨会上,讨论了32例除蕈样肉芽肿以外的皮肤T细胞淋巴瘤。本次会议聚焦于具有诊断挑战性的罕见临床和病理表现,其中细胞毒性皮肤淋巴瘤所占比例过高。会议中回顾的各种挑战性病例凸显了我们目前皮肤淋巴瘤分类的不足,并为未来的分类更新提供了丰富的学习经验。所回顾的许多病例揭示了广泛且往往令人惊讶的突变谱,这将有助于未来更精确、更具分子相关性的分类以及(可能的)治疗方法。
Thirty-two cases of cutaneous T-cell lymphoma other than mycosis fungoides were discussed at the 2023 Society of Hematopathology-European Association for Haematopathology Workshop, held November 9-11, 2023, in Houston, Texas. This session focused on diagnostically challenging rare clinical and pathologic presentations with an overrepresentation of cytotoxic cutaneous lymphomas.
The variety of challenging cases reviewed in the session highlights the shortfalls of our present cutaneous lymphoma classification and provides a rich learning experience for future classification updates. Many of the cases reviewed revealed a broad and often surprising mutational profile that will contribute to more precise and molecularly relevant future classification as well as (possibly) therapeutic approaches.
MEMBER ACCOUNT
登录成功会直接打开下一页。